OPX Technologies Gains $3.6M

Boulder, Colorado-based OPX Technologies announced today that it has raised $3.6M in a funding from MDV - Mohr Davidow Ventures, to develop economically viable biofuels and biorefined chemicals. X/Seed Capital and Rob Chess also participated in the funding. OPX is based on work from Professor Ryan Gill and Dr. Michael Lynch at the University of Colorado. According to OPX, the second round of funding follows a seed investment from X/Seed in June. As part of the funding, the firm has appointed Ron Chess as Chairman and CEO of the firm; Chess is chairman of Nektar Therapeutics. More information »